Term
Ethanolamines Diphenhydramine (Benadryl) |
|
Definition
First generation H1 blocker Sedative, non prescription sleep aid (two aromatic and two methyl groups) |
|
|
Term
Ethylenediamines Tripelennamine (PBZ) |
|
Definition
First gen H1 blocker Mildly sedative |
|
|
Term
Alkylamines Chlorpheniramine (Chlor-Trimeton) |
|
Definition
First gen H1 blocker -common ingredient in OTC cold remedies -less sedative -can inhibit reuptake of serotonin (antidepressant) |
|
|
Term
Phenothiazines Promethazine (Phenergan) |
|
Definition
First Gen H1 blocker Treatment: commonly used antiemetic with prominent sedative action Adverse Effects: contraindicated for children under 2 years of age (respiratory depression) |
|
|
Term
Piperazines Hydroxyzine (Atarax) |
|
Definition
First gen H1 blocker Treatment: widely used for chronic urticaria and dermatological allergies, sedation common Adverse Effects: contraindicated in early pregnancy |
|
|
Term
Piperazines Cyclizine (Marezine) Meclizine (Antivert) |
|
Definition
First gen H1 blocker Treatment: antiemetic |
|
|
Term
Piperidines Cyproheptadine (Periactin) Phenindamine (Nolahist) |
|
Definition
Mechanism: antihistamine, antiserotonin Adverse Effects: drowsiness and significant anticholinergic effects |
|
|
Term
H1 Antihistamines Side Effects |
|
Definition
1. CNS Toxicity. interference with NT effect of histamine through H1. Usual dose causes drowsiness, fatigue, dizziness, impairment of congnitive function and memory agitation, hallucinations. OD causes restlessness, anxiety, and convulsions (infants) 2. Cardiac Toxicity. blockade of muscarinic and alpha-adrenergic receptor; blockade of cardiac ion current. Dose related sinus tachycardia, reflex tachycardia and SV arrythmias. Dose related prolongation of QT interval and ventricular arrhythmias (diphenhydramine, hydroxyzine, etc.) 3. Other. blockade of muscarinic, alpha adrenergic, and serotonin receptors. Pupillary dilation (mydriasis), dry eye, dry mouth, urinary retention, hesitancy. Contraindicated in patients with glaucoma or prostatic hypertrophy |
|
|
Term
Piperidines Fexofenadine (Allegra) |
|
Definition
Second gen H1 blockers Lower risk of arrhythmia excreted largely unchanged in the feces up to 360mg daily dose with no side effects |
|
|
Term
|
Definition
second gen H1 blocker piperadine Metabolized by P450 system Metabolism prolonged by ketoconazole up to 10mg daily dose without side effects |
|
|
Term
Cetirizine hydrochloride (Zyrtec) |
|
Definition
second gen H1 blocker piperazine carboxylated hydroxyzine excreted largely unchanged in urine doses of 10 mg or higher causes sedation in adults |
|
|
Term
|
Definition
H2 blocker Mechanism: least potent (6hrs) Side effects: neural effects (confusion, slurred speech, delirium, hallucination, and coma) in patients with impaired renal function. Anti-androgen (gynecomastia, impotence, enhanced prolactin secretion). Interference with P450 drug metabolism pathways. Diarrhea, dizziness, rash |
|
|
Term
|
Definition
H2 blocker Mechanism: binds less to P450, long lasting (8 hrs), highly effective gastric secretion blocker |
|
|
Term
Famotidine (Pepcidine, Pepcid) |
|
Definition
H2 blocker Mechanism: does not interfere with hepatic drug metabolism pathway, most potent (12hrs), OTC |
|
|
Term
|
Definition
H2 blocker Mechanism: does not interfere with hepatic metabolism, little first pass metabolism with almost 100% bioavailability, highly potent (8hrs) |
|
|